海外の治験の状況「1」での検索結果
1245件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 地域
- 登録日
Authorised
- MK-3475 vs. Docetaxel in Second-Line Non-Small Cell Lung Cancer
- MedDRA version: 20.0 Level: LLT Classification code 10066490 Term: Progression of non-small cell lung cancer System Organ Class: 100000004864 ;Therapeutic area: Diseases [C] - Cancer [C04]
- Argentina, Australia, Belgium, Brazil, Canada, Chile, Czech Republic, Denmark, France, Germany, Greece, Hungary, Italy, Japan, Korea, Republic of, Lithuania, Netherlands, Portugal, Russian Federation, South Africa, Spain, Taiwan, United Kingdom, United States
- 2013-01-17
Not Recruiting
- Phase II trial of oral vinorelbine in a population of patients with lung cancer with an EGFR mutation, after failure to treatment with TKI in first line.
- Patients with: -Histologically or cytologically confirmed NSCLC (stage IIIB or IV) and -epidermal growth factor receptor (EGFR) positive mutation and -previously treated with tyrosine kinase inhibitor (gefitinib or erlotinib) MedDRA version: 14.1 Level: PT Classification code 10029522 Term: Non-small cell lung cancer stage IV System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) MedDRA version: 14.1 Level: PT Classification code 10029521 Term: Non-small cell lung cancer stage IIIB System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) MedDRA version: 14.1 Level: PT Classification code 10029515 Term: Non-small cell lung cancer recurrent System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area: Diseases [C] - Cancer [C04]
- Argentina, Austria, Poland, Singapore, Taiwan
- 2012-12-03
Not recruiting
- Comparative Efficacy and Safety Study of Dolutegravir and Lopinavir/Ritonavir in Second-line Treatment
- Infection, Human Immunodeficiency Virus
- Argentina, Brazil, Chile, China, Colombia, Kenya, Mexico, Peru, Romania, Russian Federation, South Africa, Thailand, Ukraine
- 2014-08-25
Not recruiting
- Impact Evaluation of the 123 Women Emergency Phone Line in Medellín, Colombia
- Violence Against Women (VAW);Violence Against Women (VAW);Violence Against Women (VAW);Violence Against Women (VAW)
- Colombia
- 2014-06-03
Not recruiting
- Bioequivalence Study Bevacizumab Biosimilar (BEVZ92) Versus Bevacizumab (AVASTIN®) in First-line Treatment mCRC Patients
- Metastatic Colorectal Cancer
- Argentina, Brazil, India, Peru, Russian Federation, Spain, Ukraine
- 2014-02-14
Not recruiting
- An Open-Label, Randomized, Phase 3 Trial of Nivolumab Versus Investigator's Choice Chemotherapy as First-Line Therapy for Stage IV or Recurrent PD-L1+ Non-Small Cell Lung Cancer (CheckMate 026)
- Stage IV or Recurrent Non-Small Cell Lung Cancer;Stage IV or Recurrent Non-Small Cell Lung Cancer;Stage IV or Recurrent Non-Small Cell Lung Cancer;Stage IV or Recurrent Non-Small Cell Lung Cancer
- Argentina, Australia, Austria, Belgium, Brazil, Canada, Czech Republic, Czechia, Finland, France, Germany, Greece, Hungary, Italy, Japan, Korea, Republic of, Mexico, Netherlands, Poland, Romania, Spain, Sweden, Switzerland, Taiwan, Turkey, United Kingdom, United States
- 2014-01-19
Not Recruiting
- Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial (BENEFIT)
- Kidney Transplantation # Chronic Kidney Failure;N18 - Chronic kidney disease
- Argentina, Australia, Austria, Belgium, Brazil, Canada, Czech Republic, France, Germany, Hungary, India, Israel, Italy, Mexico, Poland, South Africa, Spain, Sweden, Switzerland, Turkey, United States
- 2015-04-14
Authorised
- Clinical Trial Testing the Safety of Four Ramucirumab Doses Given as Second Line Treatment to Patients with Stomach Cancer
- Second Line Gastric or Gastroesophageal Junction Adenocarcinoma MedDRA version: 18.0 Level: PT Classification code 10063916 Term: Metastatic gastric cancer System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area: Diseases [C] - Cancer [C04]
- Argentina, Australia, France, Hungary, New Zealand, Poland, Romania, Russian Federation, Slovakia, United Kingdom, United States
- 2015-03-04
Not recruiting
- A Study of Pembrolizumab (MK-3475) for First Line Treatment of Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck (MK-3475-048/KEYNOTE-048)
- Recurrent Head and Neck Cancer;Metastatic Head and Neck Cancer
- Argentina, Australia, Austria, Brazil, Canada, Chile, Colombia, Czech Republic, Denmark, Estonia, Finland, Germany, Greece, Hong Kong, Hungary, Israel, Italy, Japan, Latvia, Malaysia, Mexico, Netherlands, Norway, Peru, Philippines, Poland, Russian Federation, Singapore, South Africa, Spain, Sweden, Switzerland, Taiwan, Thailand, Turkey, United Kingdom, United States
- 2015-02-03
Not recruiting
- Patient and Physician's Satisfaction After a Long Term Treatment of Glabellar Lines With Dysport®
- Glabellar Lines
- Australia, Brazil, Czech Republic, Kazakhstan, Lebanon, Russian Federation, Turkey, Ukraine
- 2015-01-29
